株式会社極東書店トップ ＞ 商品一覧 ＞ Computer Simulations in the Pharmaceutical Industry: Volume 1.
商品詳細
Computer Simulations in the Pharmaceutical Industry: Volume 1.
・ISBN 978-1-041-12837-3 paper GB£ 51.99
￥16,470.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
| 著者・編者 | Gangarapu, Kiran / Reddy Veerareddy, Prabhakar (eds.), |
|---|---|
| シリーズ | (Drugs and the Pharmaceutical Sciences) |
| 出版社 | (CRC Press, UK) |
| 出版年月 | 2026 |
| ページ数 | 240 pp. |
| 言語 | ENG |
| ニュース番号 | ＜A05-23944＞ |
解説
The application of computational modeling and simulation has extended beyond PK/PD prediction of clinical trial outcomes by defining regulatory strategy as well as optimization of therapeutic candidates. Further, regulatory agencies are accepting modeling and simulation for approval in special populations, drug-drug interactions, and dosing regimen changes. This volume provides a comprehensive coverage of drug design, chemoinformatics, molecular modeling, and computer-aided formulation development. Computer simulations play a crucial role in the pharmaceutical industry, accelerating drug discovery and development by predicting drug behavior and optimizing systems, thus reducing the need for animal testing.
Key Features
- Illustrates how computer simulations play a crucial role in the pharmaceutical industry, accelerating drug discovery and development.
- PK/PD simulations play a crucial role in optimizing dosing regimens and understanding the time course of drug effects.
- Depicts the role of computers in drug research development, both in clinical and preclinical stage by citing examples of approved FDA drugs.
- Provides case studies detailing the step-by-step process for using software such as Python for programming in the pharmaceutical industry; Gromacs, DataWarrior, AutoDock and Biovia.
- Discusses how artificial intelligence and machine learning can be used to optimize and refine simulation models.